Delivered-To: pgepnewsletter@gmail.com
Received: by 2002:a98:c004:0:b0:1eb:e128:bbe3 with SMTP id l4csp4674630eic;
        Tue, 16 Jan 2024 18:23:17 -0800 (PST)
X-Google-Smtp-Source: AGHT+IFEx1t20soe08vD2Bxp3G70NUKBULL/2Zmq+18zvM/Ef95FLX4oeM2I6Y5GYoHH4+vNYqws
X-Received: by 2002:a5d:94d9:0:b0:7bf:57b4:d500 with SMTP id y25-20020a5d94d9000000b007bf57b4d500mr2361053ior.24.1705458197012;
        Tue, 16 Jan 2024 18:23:17 -0800 (PST)
ARC-Seal: i=1; a=rsa-sha256; t=1705458196; cv=none;
        d=google.com; s=arc-20160816;
        b=QwODTjfxdtYz26+Saf3yT5sZDaylUmcukCqfKdpCX6ITIyfyj6lkaX2ciq9SxVJVoy
         PxvZUvNbRVmnlNbr1Hhi49BE3hUm7XI4V+xa77AlmnMr07gcEK2PMd+VtRT+R/Rgn7N/
         DTRyCcsRBiy3HF8NHRHRf9KmZFHXVjM9vSIdokbdM0UpxD/Rk+LrKeuiQ8Qi7bWmi7Vg
         31mhmxPhOFJxuiolqv0cE25L05oMQKcuzwduyLHiMceHGEXSQTuMf90oTfzheDiWNSZG
         Tpe3VFcBIRIwjiC4Lt8wxMy2ivp6WKYpVSZ2Y+3rFn1yhEQfiVmljnLyOHP8n/OuuoaV
         Kosg==
ARC-Message-Signature: i=1; a=rsa-sha256; c=relaxed/relaxed; d=google.com; s=arc-20160816;
        h=list-unsubscribe:to:reply-to:subject:message-id:mime-version:from
         :date:dkim-signature:dkim-signature;
        bh=wJb8ArxBQGXGljHfvwg/Ih7UBmhndbs0mYvr8hAILX8=;
        fh=m8+yFGL9AGrkSifADXzxzWHypeMVd9MF7/kbikeN2H4=;
        b=mVDKHkmyrzkIOCTAa2Qa/tDelXOx4RGFPRREhDA0gX0KorC3PYBycyrGVnd68JYr7u
         mAXGjFQkwX7n/iBYmw7a3azHYSub9pFfOPxqkevC3B8mIdLdJslK4XJRE5wxwnncwg1T
         p8TT1ZWQxAt0atQ0ivdHCZoKJP7HjdgcBpy+Ucf4sdpiV5z8Csr+mWAIl6I8BDj6W80r
         iieH7PuMxjUms1jIOZsXMRPLtgegvgWGR860PmEZF7SyD3YFWRnHJ51UArOWKLLb09pP
         s8MVE1MuY1L2rnaS9dFEmFeLib0jsUBYv15FmE8H9r0BjA/W/ncQZlMCEclibOY4DPMz
         Ligw==
ARC-Authentication-Results: i=1; mx.google.com;
       dkim=pass header.i=@isid.org header.s=s1 header.b="XzPncgB/";
       dkim=pass header.i=@sendgrid.info header.s=smtpapi header.b=HHNqVRqI;
       spf=pass (google.com: domain of bounces+19268662-547c-pgepnewsletter=gmail.com@em7004.isid.org designates 167.89.81.226 as permitted sender) smtp.mailfrom="bounces+19268662-547c-pgepnewsletter=gmail.com@em7004.isid.org";
       dmarc=pass (p=NONE sp=NONE dis=NONE) header.from=isid.org
Return-Path: <bounces+19268662-547c-pgepnewsletter=gmail.com@em7004.isid.org>
Received: from xtrwrkzn.outbound-mail.sendgrid.net (xtrwrkzn.outbound-mail.sendgrid.net. [167.89.81.226])
        by mx.google.com with ESMTPS id e1-20020a63e001000000b005b7160263f2si11712299pgh.154.2024.01.16.18.23.16
        for <pgepnewsletter@gmail.com>
        (version=TLS1_3 cipher=TLS_AES_128_GCM_SHA256 bits=128/128);
        Tue, 16 Jan 2024 18:23:16 -0800 (PST)
Received-SPF: pass (google.com: domain of bounces+19268662-547c-pgepnewsletter=gmail.com@em7004.isid.org designates 167.89.81.226 as permitted sender) client-ip=167.89.81.226;
Authentication-Results: mx.google.com;
       dkim=pass header.i=@isid.org header.s=s1 header.b="XzPncgB/";
       dkim=pass header.i=@sendgrid.info header.s=smtpapi header.b=HHNqVRqI;
       spf=pass (google.com: domain of bounces+19268662-547c-pgepnewsletter=gmail.com@em7004.isid.org designates 167.89.81.226 as permitted sender) smtp.mailfrom="bounces+19268662-547c-pgepnewsletter=gmail.com@em7004.isid.org";
       dmarc=pass (p=NONE sp=NONE dis=NONE) header.from=isid.org
DKIM-Signature: v=1; a=rsa-sha256; c=relaxed/relaxed; d=isid.org;
	h=content-type:from:mime-version:subject:reply-to:x-feedback-id:to:
	list-unsubscribe:cc:content-type:from:subject:to;
	s=s1; bh=wJb8ArxBQGXGljHfvwg/Ih7UBmhndbs0mYvr8hAILX8=;
	b=XzPncgB/tfbwUDSaMhxJjfxrNCsLB70OvKVuJsA42dl6IFpciei4kbNsjlPVDzg4Y0rU
	OwUg9VlKazVvdJ5raquy9Nd+8cMWRnXtnffCzn7hv33BZxd8Al6n5Afc3xXCXFSSHzc2vN
	Wp8uhSv4pBvhTXeVeMHHXnKXljR4DQZ1JPKE21Kmyl+SqGZ8z4+oxz/hTKRniJZfLnpbCK
	LJhx4Z0a1kv0G7oevAEzuZ9/gWvqoC0GvuxByRcvkvdZ9pjwaP5pPmjo5Iy0GD7h8YY2iK
	uzYiL8+5F94giaCjK6aNDz7euZmfp6UK4JeD9seAca9WbErF+DKWc5f1dOOvGzUg==
DKIM-Signature: v=1; a=rsa-sha256; c=relaxed/relaxed; d=sendgrid.info;
	h=content-type:from:mime-version:subject:reply-to:x-feedback-id:to:
	list-unsubscribe:cc:content-type:from:subject:to;
	s=smtpapi; bh=wJb8ArxBQGXGljHfvwg/Ih7UBmhndbs0mYvr8hAILX8=;
	b=HHNqVRqIhMndwxdSFi2Vi1b31xOgJFWcCCK1A7xgB3nTPYs88pcVTRvq+9xFZ5+Rn7Fk
	LSjtfdSHNQN5SRFlP+3XJlceH1T795HjQSGMWgv4neUy1hL25E9ZYD+0f58d/vN2U8LqoT
	uVHAOT8sfgcp5hqN1pHY+VwLYHT4NQCso=
Received: by filterdrecv-657547499f-qmsfc with SMTP id filterdrecv-657547499f-qmsfc-1-65A73A10-E
        2024-01-17 02:23:12.285909344 +0000 UTC m=+7890109.605659492
Received: from MTkyNjg2NjI (unknown)
	by geopod-ismtpd-12 (SG) with HTTP
	id BfMVDamBSSSPAkiSSpohVw
	Wed, 17 Jan 2024 02:23:12.124 +0000 (UTC)
Content-Type: multipart/alternative; boundary=c5c0f33e42d39e5ba6103bf0f3ac5c37af9ca8f436250ebb3a4e0ac85f57
Date: Wed, 17 Jan 2024 02:23:15 +0000 (UTC)
From: ProMED <promed@isid.org>
Mime-Version: 1.0
Message-ID: <BfMVDamBSSSPAkiSSpohVw@geopod-ismtpd-12>
Subject: PRO/AH/EDR> Glanders - Iraq: (BG) horse, WOAH
Reply-To: noreply@isid.org
X-Feedback-ID: 19268662:SG
X-SG-EID: 
 =?us-ascii?Q?lYKUi1ucKQwcfoVB1xAcbBSlsJP9QSi7ed2VWI0p5NjpCc5BQK+kujBGGO1mU1?=
 =?us-ascii?Q?iBXbcBryHnLtf10Ev7XseU0890e2Xwc=2FW2bkPIY?=
 =?us-ascii?Q?XejRsV6MzUMA=2FxCUUlb4ZbGl+7chEOY8SEyKK9p?=
 =?us-ascii?Q?HccoegcEZ8NRG3oUmKD6B5D6fTJgU9+vxGHJ8kT?=
 =?us-ascii?Q?OT2+5YbULxxFYYf9IV2+SS4HJDSx+hqdke6XRlz?=
 =?us-ascii?Q?P4shvvJQFO48hwTLve=2F=2FIBnu5fS9JIRnmoSwJw?=
X-SG-ID: 
 =?us-ascii?Q?se=2F49CGmbS0sfR97ImeXvNhg9p9jggtUUChgqoY2wUiShGf=2FO8XJWpH34Od4Nd?=
 =?us-ascii?Q?fxXa6jil96uRcJkF+N+LeVnO1tx80ddOyoyOo=2Fc?=
 =?us-ascii?Q?Brxcl3ERAm0cOY743=2FFH59DWiSf5OzXORh1DLKt?=
 =?us-ascii?Q?hb1NMKty3PsA5ju0ZzxCrq1WQuZSEQf=2FJlWtgqv?=
 =?us-ascii?Q?cZmsyCHlNUZsD=2Fx=2FucZ1CkY3XVctXIp=2FYgCcFll?=
 =?us-ascii?Q?Sz8qH=2F6AQXkKJhfszpf1pvsPomeIvlVLajK+lZL?=
 =?us-ascii?Q?XHdM1InMImceaSOscVmzXtqSAzw4SPsgONkHNFA?=
 =?us-ascii?Q?VbUcNJzDcH6CHtza68i2nll46sHE8YnWGNFVV0i?=
 =?us-ascii?Q?e6qTTsB=2F1ksFrJ2svm6gnKt6wAdPiaHUhJaj=2Fv5?=
 =?us-ascii?Q?zxibJN6SJWEIMBd7+C8D4M3CjT=2FG40oETjZGtwI?=
 =?us-ascii?Q?7ETTK1CinZ4FYAWUymMMHrQ56XLKwYnbO2cuRKF?=
 =?us-ascii?Q?SbCtCVEDjND7RwlJhM1Ah6LFKtVoXF+hCwU=2Fz2T?=
 =?us-ascii?Q?VJA0FeGVUBqR8DjYYDNX5m6o1ckUljIfKev9Pz3?=
 =?us-ascii?Q?UnHtApE6gke+29kYLQAjHYnv1u+sXndFiXkvjKR?=
 =?us-ascii?Q?THIKOZSGWIGPyre+cW92NeyG1dtUAa=2FnyrHNC=2Fa?=
 =?us-ascii?Q?sTRcLhsviNFMAiRft1nQuHeAVSQwx15jvjY7VT1?=
 =?us-ascii?Q?VyE3PV3byXwX=2Foy1+BQ=2F+4plO7SRH9TTjPNaxc6?=
 =?us-ascii?Q?5PvI2nFiHi5qdJWLYo3lQxkG90b7ZpIDpPSX3nq?=
 =?us-ascii?Q?YitPtpbZIIXYXzP++9jZqn5Z6r87k6GgnQ2vSCS?=
 =?us-ascii?Q?yKZRuOM9JDdfWKxsu2hBjoX7Sw=3D=3D?=
To: pgepnewsletter@gmail.com
X-Entity-ID: 3CKJgmVGbBVD214dsRqreg==
List-Unsubscribe: 
 =?us-ascii?Q?=3Cmailto=3Aunsubscribe=40em7004=2Eisid=2Eorg=3Fsubject=3D19268662=2EDO0p2cjf4?=
 =?us-ascii?Q?TEqJsoPwtk4ddLMtJFRYvg46VPKvFpH21toMDAw?=
 =?us-ascii?Q?dTAwMKWYJ4m-XpJyRxR15BjhkjOs8CVF4IrgQGG?=
 =?us-ascii?Q?fdsrCKpnP59XJ6IJRPrVEJzVV8QKgX1ahQszdJb?=
 =?us-ascii?Q?umIpn0v0vgEdHr3OU8QBh2irJAPQ3kp=5FgkFIoSw?=
 =?us-ascii?Q?QKbRYi-6y0WX19DHw=3D=3D=2EvTURigG3VQY4rkjByE1?=
 =?us-ascii?Q?oAjW3QTVOLoQN4OL2lgIehhtoMDAwdTAwMC0LAp?=
 =?us-ascii?Q?5Jnn-pf-g9IQ36XicuXJ-c7nZv1crhSW4K-HNq=5F?=
 =?us-ascii?Q?gqkWHLLWyw2ZD27TKJ1K6=5FJlZUsQz0XLTV8wtWg?=
 =?us-ascii?Q?PG8eAfREbgPEXG9Q2lNsFtgTFO2l0n972Mdz8Ux?=
 =?us-ascii?Q?9wu6BMFYanO=5FfuMP5D6C1oaoqApvrWwzKDgbIJt?=
 =?us-ascii?Q?4jjjhxDCYVsFfMs84JyVn4nh6FStxTAfp3bcvie?=
 =?us-ascii?Q?kSStTOgan5=5Fn9slURqDVCIdAvsuauXJs90EfRej?=
 =?us-ascii?Q?jjTgl2HRjFaPvFUSgghvmoj1O7yRqz4J9uOBTrN?=
 =?us-ascii?Q?59ebwbOMpbsALKXeBHT8NtbeZbUvlTYDShUjxA0?=
 =?us-ascii?Q?lSHKK=5FyM5=5FHQqTjDrXxKAJujxLUKcnMyEWXW6Rr?=
 =?us-ascii?Q?KIR0uHeoDegnD9Pxqx4vBTmLGdeU=5FxccL=5F-bi-h?=
 =?us-ascii?Q?52qhK8qjCABueijw7iYVVPT=5FI9cB7GkF=5F9QaLM7?=
 =?us-ascii?Q?rq0cWbp-RVUWM-FBIIxHq1Z5WlyapHb5YSAkzYD?=
 =?us-ascii?Q?uWSG69cn4xiNYyZEZiH6Ann7u0juVxbyMfxgWwx?=
 =?us-ascii?Q?1x55UA3oloilqW=5FO3F0gjEFdDKbpOEzYddsXR5Q?=
 =?us-ascii?Q?Mm2zlmAmuyNOuyjsa9uRSY6XUTOx9nYYkRO2wnv?=
 =?us-ascii?Q?9xIdZ2unjQgR5NUexSlmIpmCmp7UvvaQPKIoIRY?=
 =?us-ascii?Q?OQgLwHBOqVX=5FK0nWaFgYGbxC6MLKHeCPVipABzR?=
 =?us-ascii?Q?BDtN=5FCmLGav5bUblgpGfaR1qO5LpzphELlWkyEl?=
 =?us-ascii?Q?QOHtma9Ljx5AZ6URSvW9apXiWJgA06NvcJU4JIk?=
 =?us-ascii?Q?nPlAzIOiFeGBEkXs223z9Hid3ZBuzG3Pq7l2niL?=
 =?us-ascii?Q?YCU6laMqJuyaPOVhuaJ13WK1dv6mv-XdUOkvePb?=
 =?us-ascii?Q?DW0XEprHxRSfY--=5FS8wkLgXqlXMZnvWMm-FivxB?=
 =?us-ascii?Q?R2eqkHpsjcHaFRCH4iZ2=5FMQ0wrYwesBuNEtLOUm?=
 =?us-ascii?Q?e0Z7OPbqmVcwGQBQ=5ForGPwgOdC=5FGhNvSxwuDQrk?=
 =?us-ascii?Q?Wpq0WznGzy=5FabYKAvfonqpz7iRkBls1ZgoKd1Bu?=
 =?us-ascii?Q?uDrsi1FaHrGUYsFcaYY=5Fd9pmrFoAKmNSN6er54E?=
 =?us-ascii?Q?IVcizw=3D=3D=3E?=

--c5c0f33e42d39e5ba6103bf0f3ac5c37af9ca8f436250ebb3a4e0ac85f57
Content-Transfer-Encoding: quoted-printable
Content-Type: text/plain; charset=us-ascii
Mime-Version: 1.0

GLANDERS - IRAQ: (BAGHDAD) HORSE, WOAH
**************************************
A ProMED-mail post
<http://www.promedmail.org>
ProMED-mail is a program of the
International Society for Infectious Diseases
<http://www.isid.org>

Date: Sun 14 Jan 2024
Source: WOAH-WAHIS (World Animal Health Information System) [edited]
<https://wahis.woah.org/#/in-review/5485>


Iraq - _Burkholderia mallei_ (Infection with) (Glanders) - Immediate
notification
---------------------------------------------------------------------------=
-----
General information
Report type: Immediate notification
Started: 8 Jan 2024
Confirmed: 10 Jan 2024
Reported: 14 Jan 2024
End date: -
Date of last occurrence: 31 Dec 2014
Nature of diagnosis: Clinical, laboratory test
Disease: Bluetongue virus (inf. with)
Causal agent: Iraq - _Burkholderia mallei_ (Inf. with) (Glanders)
Genotype / serotype / subtype: -
Species: Equidae (domestic)
Reason for notification: Recurrence of an eradicated disease=20
Animal type: Terrestrial
Disease category: WOAH (OIE) listed disease
Event status: Ongoing

Outbreak location: Baghdad, Adhamiya=20
Started: 8 Jan 2024
Epidemiological unit: Other
Total animals affected:
Species / Susceptible / Cases / Deaths / Killed and disposed of /
Slaughtered or killed for commercial use / Vaccinated
Equidae (domestic) / 1 / 1 / - / - / - / -

Epidemiology
Source of event or origin of infection: Introduction of new live
animals

Control measures at event level
Domestic animals, applied: Disinfection, quarantine, movement control,
zoning=20

Diagnostic test result
Test name / Laboratory / Species sampled / Number of outbreaks sampled
/ First result date / Latest result date / Result
Complement fixation test for antibody detection (Ab CFT) / Iraq
Central Veterinary Laboratory / Equidae / 1 / 8 Jan 2024 / 10 Jan 2024
/ Positive

[The location of the outbreak can be seen on the interactive map
included in the WOAH report at the source URL above.]

--
Communicated by:
ProMED

["Glanders is an infectious and life-threatening disease that mainly
affects horses, donkeys or mules caused by the bacterium _Burkholderia
mallei_. Glanders can be transmitted to humans. Susceptibility to
glanders has also been demonstrated in camels, felines living in the
wild, bears, wolves, and dogs. Carnivores may become infected by
eating infected meat. Guinea pigs and hamsters are highly susceptible.
The disease causes nodules and ulcerations in the respiratory tract
and lungs in animals. A skin form, known as 'farcy', also occurs. In
humans the disease can take different forms such as: nasal, localized
with nodules and abscesses, pulmonary, septicemia with disseminated or
chronic infection, respectively. A cure is possible, however, if cases
are treated rapidly with antibiotics; fatality rates for untreated
infections are very high. Glanders remains sporadically reported in a
number of Asian, African, Middle Eastern, and South American
countries. Glanders is a disease listed in the WOAH Terrestrial Animal
Health Code and must be reported by Members according to the WOAH
Code." (<https://www.woah.org/en/disease/glanders/>). - Mod.JH

ProMED map:
Iraq: <https://promedmail.org/promed-post?place=3D8714278,89>]

[See Also:
2019
----
Glanders - Kuwait: (AH) horse, OIE
http://promedmail.org/post/20190731.6598640
2017
----
Glanders, equine - Turkey: (IB)
http://promedmail.org/post/20171206.5487492
2012
----
Glanders, equine - Brazil: (MG) OIE
http://promedmail.org/post/20120528.1147807
2011
----
Glanders, equidae: laboratory diagnosis
http://promedmail.org/post/20111102.3263
Glanders, equine - Lebanon (03): RFI
http://promedmail.org/post/20110822.2549
Glanders, equine - Syria: RFI
http://promedmail.org/post/20110731.2302
Glanders, equine - Lebanon: (BA) OIE
http://promedmail.org/post/20110713.2122
Glanders, equine - Bahrain: (North), OIE
http://promedmail.org/post/20110430.1350
Glanders, feline - Iran: (TH), tiger, lion
http://promedmail.org/post/20110122.0261
2010
----
Glanders, equine - Bahrain (04): resolved, OIE, camel, RFI
http://promedmail.org/post/20100919.3386
Glanders, equine - Bahrain http://promedmail.org/post/20100428.1364
2007
----
Glanders, equine - Iran ex Iraq
http://promedmail.org/post/20071129.3854
2004
----
Glanders, equine - United Arab Emirates: OIE
http://promedmail.org/post/20041019.2836]
.................................................mo/jh/may/jh
*##########################################################*
************************************************************
ProMED makes every effort to verify the reports that are posted, but the ac=
curacy
and completeness of the information, and of any statements or opinions base=
d
thereon, are not guaranteed. The reader assumes all risks in using informat=
ion
posted or archived by ProMED. ISID and its associated service providers sha=
ll not
be held responsible for errors or omissions or held liable for any damages =
incurred
as a result of use or reliance upon posted or archived material.
************************************************************
Donate to ProMED. Details available at: https://isid.networkforgood.com/pro=
jects/79924-invest-in-the-mission.
************************************************************
Visit ProMED's website at https://www.promedmail.org/.
Submit all items for posting via the ProMED website at https://promedmail.o=
rg/submitinfo/.
If you have any questions or need support, please contact us via the ProMED=
 website at  https://promedmail.org/support/.
You may subscribe/unsubscribe at  https://isid.org/promedmail-subscribe/.
Unsubscribe Preferences ( https://u19268662.ct.sendgrid.net/asm/?user_id=3D=
19268662&data=3DG98zCPT0ky_mg0_XKWlV3vfUhaT-DaiWuAuxvbDT5jpoMDAwdTAwMHWoXzJ=
YOM9-2--nhw8vQ7tGINUWlQ9QjAIIX1Y93LTRxZaChNh6JA7UUEziodcWqsQ77D2A8nwJAlpN2F=
Nn5Cx6j3Jufxgcr5rRIok_bwvUEMrCPPEQzK9gwUop0SsVWH4XkyBdSWLfzUD1plYd9oQsDZ6OU=
416p0oGklAkEN92mAqTx4E__Qz4YmWeNRVTw8SHztu8Tvm9C442oPSzf4wxfmW_IrVs_k6LtkHJ=
pzPO-o-meKr50sHFgLg6gW9GZlzsrMNnNEDZjBguP63ysx-xbYh0wej7nQtys8marNWTmnoBLQk=
njWgzI5WIlKRfAPXybfDgoVtPHfaSQmLa4KIJPQd_N4RSCtePJEZtcgxrAzQLfuQQHYzc2QCXrq=
hUrTjtcPdpEwHXjJadCdUd5N3TBLCtNxZZqIU_jWqAWYldhNucvOBPaaRRmzwj9JlJhBOKz5nJg=
NNm08mPYA8XO8LTltwallMu26dgsJyTCrRB5bvzRfuMnKHNGjHJM_MKv8k_8gHHF4YT_JSlqhqu=
SvTeB4jIuMAxHqYw0srt2sgqLwWp172P7zzB3FT3gf-fSRqn63yOchhBjrFeY_J1BPapG4XH1qm=
xaoUj9Tf6n8RXdHK0ynMjY7WitE_yZU60-00X0kAWhzCXL5X7sAy4M-FduPIqc2gInhO54_i9s2=
7SbLavdiKPAtTQCOPNj0-r5jDx7cjw6U8QyiNkcK2_8sTE2Hse6meoYuh1h_6z3uorZ43VE6rQQ=
R5pxGA2lkSy-UAWVXcAXBC_g8uB1wmiIDSMBNky05aQ2E70X54ssTKbgY96nV_ZgCjpoZQPQGJg=
LWUpVt_GZAa6WLIJmCYivPAQVkhvMGr5BeYsv2MFvSMcrfiO9g-exQjCiryfRLQ0j0sJpDUTdoA=
JuVwHorS32OFW0kcAxABT2ppJeh9CSyOSHhyRuYK5AmeGFKIeCeXl9vCPNI3cq824P0xEp55ueL=
_GfFBXPfU6FsNVfDZPPaUTGFavmMwKG3pMInz9Y9p-qqiCu6Muujg-EV19kYp_Bi7rzD8zTt06q=
uEBslmcLxWJCV6M3b0mWp8qT3-NSkNH-xmWWkXtnPPZxuvt5tKJqjp1VaWfSv3cvY-q3q-n2JoR=
OMakBG7qYVlOujqpUcdTErTaBrzYlZH5pUVOffpBe9n_UXqs8C5CwoDITUK7LHc2 )
############################################################
############################################################

--c5c0f33e42d39e5ba6103bf0f3ac5c37af9ca8f436250ebb3a4e0ac85f57
Content-Transfer-Encoding: quoted-printable
Content-Type: text/html; charset=us-ascii
Mime-Version: 1.0

<!DOCTYPE HTML>
<html>
<head>
<meta http-equiv=3D"Content-Type" content=3D"text/html; charset=3DUTF-8" />
</head>
<body>GLANDERS - IRAQ: (BAGHDAD) HORSE, WOAH<br>***************************=
***********<br>A ProMED-mail post<br><a href=3D"https://u19268662.ct.sendgr=
id.net/ss/c/wscE2ng5fl6JrPIt48tisIijpefK5PNjW-mL-YZGnfgDOxU1G3gjwnPSi2Tfv3H=
A/432/Db7_52XnSsaTyEPBFHjYBQ/h0/YXkOt9-0Tt1P-FvVifYE6pX6wfzPuPaUSLPghLN9_c0=
">http://www.promedmail.org</a><br>ProMED-mail is a program of the<br>Inter=
national Society for Infectious Diseases<br><a href=3D"https://u19268662.ct=
.sendgrid.net/ss/c/wscE2ng5fl6JrPIt48tisCT5tpD4Upm3qyMCbcYSQvc/432/Db7_52Xn=
SsaTyEPBFHjYBQ/h1/o8pRvwUlS_jn8yky7j5oWcLzFhyIKJAinvFxOI5d3GY">http://www.i=
sid.org</a><br><br>Date: Sun 14 Jan 2024=0D<br>Source: WOAH-WAHIS (World An=
imal Health Information System) [edited]=0D<br><a href=3D"https://u19268662=
.ct.sendgrid.net/ss/c/TLh_csrC34X_iXpbYoMam-hfNBcjkmqx8p5hLSO19IN38ZLaN-nCE=
iF7d2InyIhO/432/Db7_52XnSsaTyEPBFHjYBQ/h2/ji1rLwLsvFJlsUJicYOJcp1mLlm_f8YC4=
3vNvGMNX6U">https://wahis.woah.org/#/in-review/5485</a>=0D<br>=0D<br>=0D<br=
>Iraq - _Burkholderia mallei_ (Infection with) (Glanders) - Immediate<br>no=
tification=0D<br>----------------------------------------------------------=
----------------------=0D<br>General information=0D<br>Report type: Immedia=
te notification=0D<br>Started: 8 Jan 2024=0D<br>Confirmed: 10 Jan 2024=0D<b=
r>Reported: 14 Jan 2024=0D<br>End date: -=0D<br>Date of last occurrence: 31=
 Dec 2014=0D<br>Nature of diagnosis: Clinical, laboratory test=0D<br>Diseas=
e: Bluetongue virus (inf. with)=0D<br>Causal agent: Iraq - _Burkholderia ma=
llei_ (Inf. with) (Glanders)=0D<br>Genotype / serotype / subtype: -=0D<br>S=
pecies: Equidae (domestic)=0D<br>Reason for notification: Recurrence of an =
eradicated disease=20=0D<br>Animal type: Terrestrial=0D<br>Disease category=
: WOAH (OIE) listed disease=0D<br>Event status: Ongoing=0D<br>=0D<br>Outbre=
ak location: Baghdad, Adhamiya=20=0D<br>Started: 8 Jan 2024=0D<br>Epidemiol=
ogical unit: Other=0D<br>Total animals affected:=0D<br>Species / Susceptibl=
e / Cases / Deaths / Killed and disposed of /<br>Slaughtered or killed for =
commercial use / Vaccinated=0D<br>Equidae (domestic) / 1 / 1 / - / - / - / =
-=0D<br>=0D<br>Epidemiology=0D<br>Source of event or origin of infection: I=
ntroduction of new live<br>animals=0D<br>=0D<br>Control measures at event l=
evel=0D<br>Domestic animals, applied: Disinfection, quarantine, movement co=
ntrol,<br>zoning=20=0D<br>=0D<br>Diagnostic test result=0D<br>Test name / L=
aboratory / Species sampled / Number of outbreaks sampled<br>/ First result=
 date / Latest result date / Result=0D<br>Complement fixation test for anti=
body detection (Ab CFT) / Iraq<br>Central Veterinary Laboratory / Equidae /=
 1 / 8 Jan 2024 / 10 Jan 2024<br>/ Positive=0D<br>=0D<br>[The location of t=
he outbreak can be seen on the interactive map<br>included in the WOAH repo=
rt at the source URL above.]=0D<br>=0D<br>--=0D<br>Communicated by:=0D<br>P=
roMED<br><br>["Glanders is an infectious and life-threatening disease that =
mainly<br>affects horses, donkeys or mules caused by the bacterium _Burkhol=
deria<br>mallei_. Glanders can be transmitted to humans. Susceptibility to<=
br>glanders has also been demonstrated in camels, felines living in the<br>=
wild, bears, wolves, and dogs. Carnivores may become infected by<br>eating =
infected meat. Guinea pigs and hamsters are highly susceptible.<br>The dise=
ase causes nodules and ulcerations in the respiratory tract<br>and lungs in=
 animals. A skin form, known as 'farcy', also occurs. In<br>humans the dise=
ase can take different forms such as: nasal, localized<br>with nodules and =
abscesses, pulmonary, septicemia with disseminated or<br>chronic infection,=
 respectively. A cure is possible, however, if cases<br>are treated rapidly=
 with antibiotics; fatality rates for untreated<br>infections are very high=
. Glanders remains sporadically reported in a<br>number of Asian, African, =
Middle Eastern, and South American<br>countries. Glanders is a disease list=
ed in the WOAH Terrestrial Animal<br>Health Code and must be reported by Me=
mbers according to the WOAH<br>Code." (<a href=3D"https://u19268662.ct.send=
grid.net/ss/c/TLh_csrC34X_iXpbYoMam2-QLiHwCJ8Scfe29XK2hdxlk-79cN8y4m-FLA7SX=
_fNbZFxmK6SV3ONwnoTvI__1Q/432/Db7_52XnSsaTyEPBFHjYBQ/h3/relod4wM1QN7-YduEge=
D-BlCFlPk7Cq_W3S-MNq30XQ">https://www.woah.org/en/disease/glanders/</a>). -=
 Mod.JH<br><br>ProMED map:<br>Iraq: <a href=3D"https://u19268662.ct.sendgri=
d.net/ss/c/sSnCkKCWBvais3EuVAOvgy2WOIX7pp1nXnn4AbwuQ3Z6WbkfhqXYXU-aTMPJ8yTh=
B28nq4GMn8y1rRITROvsiQ/432/Db7_52XnSsaTyEPBFHjYBQ/h4/aapDuDanIdXfVifJEnB8YM=
KvgeL5hFQGrIuh-C52Zcs">https://promedmail.org/promed-post?place=3D8714278,8=
9</a>]<br><br>[See Also:<br>2019=0D<br>----=0D<br>Glanders - Kuwait: (AH) h=
orse, OIE<br>http://promedmail.org/post/20190731.6598640=0D<br>2017=0D<br>-=
---=0D<br>Glanders, equine - Turkey: (IB)<br>http://promedmail.org/post/201=
71206.5487492=0D<br>2012=0D<br>----=0D<br>Glanders, equine - Brazil: (MG) O=
IE<br>http://promedmail.org/post/20120528.1147807=0D<br>2011=0D<br>----=0D<=
br>Glanders, equidae: laboratory diagnosis<br>http://promedmail.org/post/20=
111102.3263=0D<br>Glanders, equine - Lebanon (03): RFI<br>http://promedmail=
.org/post/20110822.2549=0D<br>Glanders, equine - Syria: RFI<br>http://prome=
dmail.org/post/20110731.2302=0D<br>Glanders, equine - Lebanon: (BA) OIE<br>=
http://promedmail.org/post/20110713.2122=0D<br>Glanders, equine - Bahrain: =
(North), OIE<br>http://promedmail.org/post/20110430.1350=0D<br>Glanders, fe=
line - Iran: (TH), tiger, lion<br>http://promedmail.org/post/20110122.0261=0D=
<br>2010=0D<br>----=0D<br>Glanders, equine - Bahrain (04): resolved, OIE, c=
amel, RFI<br>http://promedmail.org/post/20100919.3386=0D<br>Glanders, equin=
e - Bahrain http://promedmail.org/post/20100428.1364=0D<br>2007=0D<br>----=0D=
<br>Glanders, equine - Iran ex Iraq<br>http://promedmail.org/post/20071129.=
3854=0D<br>2004=0D<br>----=0D<br>Glanders, equine - United Arab Emirates: O=
IE<br>http://promedmail.org/post/20041019.2836]<br>........................=
.........................mo/jh/may/jh<br></body>
</html><!DOCTYPE HTML>
<html>
<head>
<meta http-equiv=3D"Content-Type" content=3D"text/html; charset=3DUTF-8" />
</head>
<body>*##########################################################*<br>*****=
*******************************************************<br>ProMED makes eve=
ry effort to verify the reports that are posted, but the accuracy<br>and co=
mpleteness of the information, and of any statements or opinions based<br>t=
hereon, are not guaranteed. The reader assumes all risks in using informati=
on<br>posted or archived by ProMED. ISID and its associated service provide=
rs shall not<br>be held responsible for errors or omissions or held liable =
for any damages incurred<br>as a result of use or reliance upon posted or a=
rchived material.<br>******************************************************=
******<br>Donate to ProMED. Details available at: https://isid.networkforgo=
od.com/projects/79924-invest-in-the-mission.<br>***************************=
*********************************<br>Visit ProMED's website at https://www.=
promedmail.org/.<br>Submit all items for posting via the ProMED website at =
https://promedmail.org/submitinfo/.<br>If you have any questions or need su=
pport, please contact us via the ProMED website at  https://promedmail.org/=
support/.<br>You may subscribe/unsubscribe at  https://isid.org/promedmail-=
subscribe/.<br><div><a href=3D"https://u19268662.ct.sendgrid.net/asm/?user_=
id=3D19268662&amp;data=3DG98zCPT0ky_mg0_XKWlV3vfUhaT-DaiWuAuxvbDT5jpoMDAwdT=
AwMHWoXzJYOM9-2--nhw8vQ7tGINUWlQ9QjAIIX1Y93LTRxZaChNh6JA7UUEziodcWqsQ77D2A8=
nwJAlpN2FNn5Cx6j3Jufxgcr5rRIok_bwvUEMrCPPEQzK9gwUop0SsVWH4XkyBdSWLfzUD1plYd=
9oQsDZ6OU416p0oGklAkEN92mAqTx4E__Qz4YmWeNRVTw8SHztu8Tvm9C442oPSzf4wxfmW_IrV=
s_k6LtkHJpzPO-o-meKr50sHFgLg6gW9GZlzsrMNnNEDZjBguP63ysx-xbYh0wej7nQtys8marN=
WTmnoBLQknjWgzI5WIlKRfAPXybfDgoVtPHfaSQmLa4KIJPQd_N4RSCtePJEZtcgxrAzQLfuQQH=
Yzc2QCXrqhUrTjtcPdpEwHXjJadCdUd5N3TBLCtNxZZqIU_jWqAWYldhNucvOBPaaRRmzwj9JlJ=
hBOKz5nJgNNm08mPYA8XO8LTltwallMu26dgsJyTCrRB5bvzRfuMnKHNGjHJM_MKv8k_8gHHF4Y=
T_JSlqhquSvTeB4jIuMAxHqYw0srt2sgqLwWp172P7zzB3FT3gf-fSRqn63yOchhBjrFeY_J1BP=
apG4XH1qmxaoUj9Tf6n8RXdHK0ynMjY7WitE_yZU60-00X0kAWhzCXL5X7sAy4M-FduPIqc2gIn=
hO54_i9s27SbLavdiKPAtTQCOPNj0-r5jDx7cjw6U8QyiNkcK2_8sTE2Hse6meoYuh1h_6z3uor=
Z43VE6rQQR5pxGA2lkSy-UAWVXcAXBC_g8uB1wmiIDSMBNky05aQ2E70X54ssTKbgY96nV_ZgCj=
poZQPQGJgLWUpVt_GZAa6WLIJmCYivPAQVkhvMGr5BeYsv2MFvSMcrfiO9g-exQjCiryfRLQ0j0=
sJpDUTdoAJuVwHorS32OFW0kcAxABT2ppJeh9CSyOSHhyRuYK5AmeGFKIeCeXl9vCPNI3cq824P=
0xEp55ueL_GfFBXPfU6FsNVfDZPPaUTGFavmMwKG3pMInz9Y9p-qqiCu6Muujg-EV19kYp_Bi7r=
zD8zTt06quEBslmcLxWJCV6M3b0mWp8qT3-NSkNH-xmWWkXtnPPZxuvt5tKJqjp1VaWfSv3cvY-=
q3q-n2JoROMakBG7qYVlOujqpUcdTErTaBrzYlZH5pUVOffpBe9n_UXqs8C5CwoDITUK7LHc2" =
target=3D"_blank" class=3D"Unsubscribe--unsubscribePreferences" style=3D"fo=
nt-family:sans-serif;text-decoration:none;">Unsubscribe Preferences</a></di=
v><br>############################################################<br>#####=
#######################################################<br><br><img src=3D"=
https://u19268662.ct.sendgrid.net/ss/o/LbtalBvHhFtzyiegKfBhew/432/Db7_52XnS=
saTyEPBFHjYBQ/ho.gif" alt=3D"" width=3D"1" height=3D"1" border=3D"0" style=
=3D"height:1px !important;width:1px !important;border-width:0 !important;ma=
rgin-top:0 !important;margin-bottom:0 !important;margin-right:0 !important;=
margin-left:0 !important;padding-top:0 !important;padding-bottom:0 !importa=
nt;padding-right:0 !important;padding-left:0 !important;"/></body>
</html>
--c5c0f33e42d39e5ba6103bf0f3ac5c37af9ca8f436250ebb3a4e0ac85f57--
